Endothelial cell activation by antiphospholipid antibodies.
about
Accelerated atherosclerosis in patients with SLE--mechanisms and managementBlocking the glucocorticoid receptor with RU-486 does not prevent glucocorticoid control of autoimmune mouse hearing loss.Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2.Platelets are required for enhanced activation of the endothelium and fibrinogen in a mouse thrombosis model of APS.The prevalence of positive serum anticardiolipin antibodies and asymptomatic bacteriuria in women with recurrent abortions.Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome.Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studiesA Case of Microangiopathic Antiphospholipid-Associated Syndromes during Pregnancy: Review of the LiteratureInfectious origin of the antiphospholipid syndrome.Antiphospholipid antibodies: effects on trophoblast and endothelial cells.Pregnancies complicated with antiphospholipid syndrome: the pathogenic mechanism of antiphospholipid antibodies: a review of the literature.Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention.Some antiphospholipid antibodies bind to hemostasis and fibrinolysis proteases and promote thrombosis.Atherosclerotic plaques occur in absence of intima-media thickening in both systemic sclerosis and systemic lupus erythematosus: a duplexsonography study of carotid and femoral arteries and follow-up for cardiovascular events.Platelets express three different splice variants of ApoER2 that are all involved in signaling.Toll-like receptors play a crucial part in the pathophysiological activity of antiphospholipid antibodies.Do adverse pregnancy outcomes contribute to accelerated cardiovascular events seen in young women with systemic lupus erythematosus?Prevention of Recurrent Thrombosis in Antiphospholipid Syndrome: Different from the General Population?Thin-layer chromatography immunostaining in detecting anti-phospholipid antibodies in seronegative anti-phospholipid syndrome.Circulating anti-beta2-glycoprotein I antibodies are associated with endothelial dysfunction, inflammation, and high nitrite plasma levels in patients with intermittent claudication.The association of anti-phospholipid antibodies with parity in placental malaria.Essential role of the p38 mitogen-activated protein kinase pathway in tissue factor gene expression mediated by the phosphatidylserine-dependent antiprothrombin antibody.Detrimental roles of TNF-alpha in the antiphospholipid syndrome and de novo synthesis of antiphospholipid antibodies induced by biopharmaceuticals against TNF-alpha.Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis.Anti-beta-2 glycoprotein I antibodies affect Bcl-2 and Bax trophoblast expression without evidence of apoptosis.Toll-like receptor 4 (TLR4) gene polymorphisms in celiac diseaseIdentification and characterization of IgA antibodies against β2-glycoprotein I in childhood Henoch-Schönlein purpura
P2860
Q26820245-016C59F4-E65E-4CD0-B85B-FFE50820FD45Q30478834-3351DB2B-0CB7-4BA4-8C27-E039028CFA73Q30497721-5B7DF0C9-B78B-4499-823A-B25EC9508B26Q33948737-D936D62F-2635-46B0-9CC8-4C10B216B5D9Q34667153-07730F83-D14C-435D-A178-2D7F0412B106Q35849691-D6041CF8-F858-44FE-B19E-14D3F07EF46FQ36013878-4573EC9B-17C1-4885-8D45-BB5B3895BF6FQ36090804-CC02625D-7A0F-4797-A5FC-AD7179F35B07Q36339540-DBC6BAA4-5DF5-456E-9C49-F7889322B378Q36881604-35C77A02-B9AD-4E9B-A0D9-86B372A97359Q36951078-B926BA9D-82FD-41C1-B6D2-742401CBB7BEQ37033345-E9E93CF1-B4D4-4C90-86BD-F78A8A06AB51Q37283026-1D215E4C-034D-4A19-8665-50C2DDDBB0E5Q37690605-4C9C99FB-1AC4-40BB-B4C8-DF45CFB0ED81Q38302213-0D90FCB2-4477-47B3-A3DE-B36CAAEF2826Q38497394-F9652F80-CB89-48AC-A7B7-6526AE7C6A48Q38654271-0D8F364D-7C22-40DA-B551-7569BB2E363FQ38794847-D3AF0451-0E6F-4ABF-96BE-9547B9B8261CQ39404443-072E1501-FD9E-4F28-935D-A6BD625BBB7DQ41989452-93577931-98BD-41E8-A109-67B6C026406AQ46811065-87F567DD-79B4-465C-A595-C7581D17FAFAQ47954105-3D07C7B8-FBBF-4EE8-A31F-66AA3DEBBE08Q48192268-B653C83C-798A-4072-9EA7-336144DEEEAAQ50052184-2A1A71A1-8F8E-4959-B96E-CBF2D703C232Q54591463-F5EBFF39-4F0A-4D0F-9062-38056636F545Q57655496-347FCE1E-D7A2-42B5-941D-A16182E7D818Q58621153-9B2606A2-AE8F-4006-8C66-48EC8343F8BE
P2860
Endothelial cell activation by antiphospholipid antibodies.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Endothelial cell activation by antiphospholipid antibodies.
@ast
Endothelial cell activation by antiphospholipid antibodies.
@en
type
label
Endothelial cell activation by antiphospholipid antibodies.
@ast
Endothelial cell activation by antiphospholipid antibodies.
@en
prefLabel
Endothelial cell activation by antiphospholipid antibodies.
@ast
Endothelial cell activation by antiphospholipid antibodies.
@en
P1433
P1476
Endothelial cell activation by antiphospholipid antibodies.
@en
P2093
P304
P356
10.1016/J.CLIM.2004.02.015
P577
2004-08-01T00:00:00Z